Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 31, 2022Medtronic presence to include 1 3 data presentations, a LinkedIn Livestream featuring Que Dallara, EVP & President, Medtronic Diabetes, comprehensive exhibit booth with presentations and a product theatre
Medtronic plc, the global leader in medical technology, today announced its participation at the American Diabetes Association (ADA) 82nd scientific sessions virtual meeting, June 3-7, 2022....
-
Apr 27, 2022Results were presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
Medtronic reported study results from the extended study phase of its MiniMed™ 780G system[i] pivotal trial with new data using its no-calibration, non-adjunctive Guardian™ 4 sensor[ii]. The...
-
Apr 25, 2022
Medtronic plc, the global leader in medical technology, today announced its participation at the 15th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD), taking...
-
Apr 20, 2022
Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for its advanced insulin delivery system, MiniMed 780G, has been recently expanded across two more...
-
Mar 14, 2022
Medtronic plc, a global leader in healthcare technology, today announced that reimbursement for continuous glucose monitoring (CGM), a key diabetes technology has been recently expanded or...
